CHUL
2705, boulevard Laurier
R-0-709
Québec, Québec
Canada G1V 4G2

Dernières nouvelles

Information non disponible

33 enregistrements « 1 de 7 »

Bolduc M, Baz M, Laliberte-Gagne ME, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Article de revue

Nanomedicine, 2018, ISSN: 1549-9634.

Résumé | Liens:

Tu V, Abed Y, Fage C, Baz M, Boivin G

Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.

Article de revue

Antiviral Res, 154 , p. 110-115, 2018, ISSN: 0166-3542.

Résumé | Liens:

Piret J, Carbonneau J, Rheaume C, Baz M, Boivin G

Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.

Article de revue

J Gen Virol, 99 (2), p. 209-218, 2018, ISSN: 0022-1317.

Résumé | Liens:

Boonnak K, Matsuoka Y, Wang W, Suguitan AL Jr, Chen Z, Paskel M, Baz M, Moore I, Jin H, Subbarao K

Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.

Article de revue

J Virol, 91 (15), 2017, ISSN: 0022-538X.

Résumé | Liens:

Retamal M, Abed Y, Rheaume C, Baz M, Boivin G

In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site.

Article de revue

J Gen Virol, 98 (6), p. 1224-1231, 2017, ISSN: 0022-1317.

Résumé | Liens:

33 enregistrements « 1 de 7 »